Quick Takeaways
- Christopher I. Wright has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,060,527.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Christopher I. Wright
- Location
- Dublin 4, Ireland
- Summary
- The estimated net worth of Christopher I. Wright is at least $1,060,527 dollars as of 17 Apr 2026. Christopher I. Wright is the Director of Alkermes plc. and owns shares of Alkermes plc. (ALKS) stock worth about $729.7K. Christopher I. Wright is the Chief Medical Officer of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $330.8K.
- Signature
- /s/ Christopher I. Wright
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher I. Wright and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Alkermes plc. ($729,742).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christopher I. Wright
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALKS | Alkermes plc. | Director | $729,742 | 08 Jun 2025 | ||
| WVE | Wave Life Sciences Ltd. | Chief Medical Officer | $330,785 | 09 Apr 2026 |
Insider Transactions Reported by Christopher I. Wright:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.